Medpace Holdings, Inc.
MEDPMedpace Holdings, Inc. is a global clinical research organization (CRO) based in Cincinnati, Ohio, employing approximately 6,000 people. Operating under a full-service model, the company also offers global central laboratory, imaging core laboratory, and bioanalytical laboratory services, as well as a Phase I unit located on its headquarters and clinical research campus in Cincinnati, Ohio.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Oct 21, 2026
14dMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
MEDP Earnings Report
EPS Est: $4.45 | FQ end Sep/2026 | Call: amc
No drugs found in this phase.
Full breakdown — the signals behind the verdict
Frequently asked questions
When is Medpace Holdings, Inc.'s next FDA catalyst?→
Medpace Holdings, Inc.'s (MEDP) next tracked catalyst is a Earnings expected October 21, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track MEDP biotech catalysts?→
Add MEDP to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Medpace Holdings, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.